Consolidated Planning Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621K | Sell |
797
-296
| -27% | -$231K | 0.08% | 135 |
|
|
2025
Q1 | $903K | Sell |
1,093
-95
| -8% | -$78.5K | 0.12% | 114 |
|
|
2024
Q4 | $917K | Sell |
1,188
-4,066
| -77% | -$3.14M | 0.12% | 103 |
|
|
2024
Q3 | $4.65M | Buy |
5,254
+2,057
| +64% | +$1.82M | 0.69% | 53 |
|
|
2024
Q2 | $2.89M | Buy |
3,197
+2,031
| +174% | +$1.84M | 0.48% | 66 |
|
|
2024
Q1 | $907K | Buy |
1,166
+19
| +2% | +$14.8K | 0.16% | 91 |
|
|
2023
Q4 | $669K | Buy |
1,147
+141
| +14% | +$82.2K | 0.12% | 101 |
|
|
2023
Q3 | $540K | Sell |
1,006
-4
| -0.4% | -$2.15K | 0.12% | 104 |
|
|
2023
Q2 | $474K | Buy |
+1,010
| New | +$474K | 0.1% | 115 |
|
|
2021
Q4 | – | Sell |
-294
| Closed | -$68K | – | 278 |
|
|
2021
Q3 | $68K | Buy |
+294
| New | +$68K | 0.04% | 136 |
|